Equipping cancer-fighting immune cells with chimeric antigen receptor (CAR) has gained
immense attention for cancer treatment. CAR-engineered T cells (CAR T cells) are the first …

The pivotal role of the tumor microenvironment (TME) in the initiation and advancement of
hepatocellular carcinoma (HCC) is widely acknowledged, as it fosters the proliferation and …

Natural killer (NK) cells exhibit a good therapeutic efficacy against various malignant cancer
cells. However, the therapeutic efficacy of plain NK cells is relatively low due to inadequate …

Background and purpose Tumor recurrence after liver transplantation (LT) impedes the
curative chance for hepatocellular carcinoma (HCC) patients. This study aimed to develop a …

Globally, hepatocellular carcinoma (HCC) is one of the most lethal malignant tumors.
Studies have shown that alterations in the tumor immune microenvironment (TIME) play a …

Hepatocellular carcinoma (HCC) remains a global health challenge. Novel treatment
modalities are urgently needed to extend the overall survival of patients. The liver plays an …

Despite advances in cancer treatment, hepatocellular carcinoma (HCC), the most common
form of liver cancer, remains a major public health problem worldwide. The immune …

Acute liver failure caused by drug overdose is a significant clinical problem in developed
countries. Acetaminophen (APAP), a widely used analgesic and antipyretic drug, but its …

This comprehensive review explores the intricate mechanisms of PANoptosis and its
implications in cancer. PANoptosis, a convergence of apoptosis, pyroptosis, and …

Liver fibrosis accompanies the development of various chronic liver diseases and promotes
their progression. It is characterized by the abnormal accumulation of extracellular matrix …